	Machine Learning Models for Predicting Antipsychotic Effectiveness and Separate Cost-Effectiveness Analysis in Hospitalized Schizophrenia Patients. Neuropsychiatr Dis Treat Zhang J, Xu Q, Jiang W, Sun D, Peng L. PMID: 41834990 [PubMed - as supplied by publisher]
	CINP: a causality-informed framework for generalizable and replicable neuroimaging prediction of antipsychotic response in schizophrenia. Biol Psychiatry Xiao Y, Li M, Liao J, Yan J, Li Z, Guo H, Pu C, Yu X, Zhang D, Yue W, Yan H. PMID: 41833746 [PubMed - as supplied by publisher]
	Association between Toxoplasma gondii IgG seropositivity and schizophrenia: A case-control study in Colombia. Schizophr Res Cano JF, Galindo-Pita S, Méndez D, Vallejo-Silva A, Córdoba R, Mejía-Salgado G, Nessim J, Torres-Morales E, Valencia MC, Gómez-Marín JE, de-la-Torre A. PMID: 41833571 [PubMed - as supplied by publisher]
	A call for action: Closing the evidence gap in management of stimulant-induced psychosis. Addiction Bouthillier A, Sharafi H, Bisaga A, Jutras-Aswad D. PMID: 41833512 [PubMed - as supplied by publisher]
	Beyond artificial intelligence psychosis: a functional typology of large language model-associated psychotic phenomena. Lancet Digit Health Flathers M, Roux S, Torous J. PMID: 41833467 [PubMed - as supplied by publisher]
	Rethinking language, cognition and assessment in psychosis: How bilingualism challenges psychiatry and how natural language processing can help. Schizophrenia (Heidelb) Just SA, DeLuca V, Rothman J, Elvevåg B. PMID: 41832255 [PubMed - as supplied by publisher]
	Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model study. Lancet Psychiatry Perry BI, Osimo EF, Si S, Hitchins KVB, Lewis C, Laws B, Griffin SJ, Khandaker GM, Murray GK, Shiers D, Chew-Graham CA, Jones PB, Denniston AK, Bardus M, Jowett S, Walsh AEL, Arshad S, Formanek T, Pillinger T, McCutcheon RA, Holt RIG, Heyse S, Rambousek M, Whiteley K, Upthegrove R, Ensor J, PsyMetRiC Network. PMID: 41831468 [PubMed - as supplied by publisher]
	Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis-Application in a Real-World Setting. Hum Psychopharmacol Heald A, Illangasekera Y, Loureiro CM, Shakespeare M, Jameson A, Phillipson A, Reynolds GP, Dalton C. PMID: 41831324 [PubMed - indexed for MEDLINE]
	Classification of functional near-infrared spectroscopy (fNIRS) signals in schizophrenia and bipolar disorder using deep learning methods. Psychiatry Res Mou L, Gong B, Tan Q, Wang H, Zhang X, Cui R, Wang Z, Shen Z. PMID: 41831295 [PubMed - as supplied by publisher]
	Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review. Schizophr Res Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J. PMID: 41830808 [PubMed - as supplied by publisher]
	Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety. Curr Pharm Biotechnol Blum K, Lewandrowski APL, Sharafshah A, Pinhasov A, Mohankumar K, Gold MS, Fuehrlein B, Elman I, Dennen C, Thanos PK, Bowirrat A, Baron D, Modestino EJ, Jafari N, Zeine F, Sunder K, Makale MT, Lorio MP, Khalsa J, Schmidt SL, Fiorelli RKA, Weinstein A, Lindenau M, Lewandrowski KU, Alves ÓL, Mahajan S, Mahajan Y, Badgaiyan RD. PMID: 41830575 [PubMed - as supplied by publisher]
	Digital Cognitive-Motor Occupational Training with QEEG Monitoring in Schizophrenia Rehabilitation: An Exploratory Neurofunctional Study. Occup Ther Int Khemthong S, Rueankam M, Chatthong W. PMID: 41830156 [PubMed - indexed for MEDLINE]
	Antipsychotic Medications in Parkinson's Disease Psychosis; A Systematic Review of Double-Blind, Randomised, Placebo-Controlled Trials. Healthcare (Basel) McKeown CJ, Salmoiraghi A. PMID: 41827650 [PubMed]
	Exploring Sex Differences in Physical Activity Patterns Among Individuals with Schizophrenia Spectrum Disorders: Insights from the Diapason Project. J Clin Med Martinelli A, Toffol E, Moncalieri G, Leone S, Santambrogio J, Starace F, Zamparini M, Carnevale M, de Girolamo G, Calza S, DIAPASON Consortium. PMID: 41827202 [PubMed]
	Co-Occurrence of Avoidant/Restrictive Food Intake Disorder (ARFID) and Schizophrenia-Spectrum Disorders: A Comprehensive Review. J Clin Med Anesini MB, Margoni S, Moccia L, Barbonetti S, Onori L, Valle EL, D'Onofrio AM, Focà F, Pinto M, Kotzalidis GD, Conti F, Sani G. PMID: 41827119 [PubMed]
	Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia. Schizophr Res Targum SD, Watson C, Claxton A, Nicolas P, Novak KD, Kaul I, Marder SR, Lin WC, Horan WP, Marcus R, Brannan SK. PMID: 41825117 [PubMed - as supplied by publisher]
	Factors Influencing Self-Stigma in the First Year of First-Episode Psychosis. Early Interv Psychiatry Rolduà-Ros J, Vila-Badia R, Abella M, Colomer-Salvans A, Serra-Arumí C, Corbella-Sotil A, Carmona A, Rubio-Abadal E, N DC, Butjosa A, Moreno-Poyato AR, Lluch-Canut T, J T, Jiménez-Fernández B, PROFEP Group, Usall J. PMID: 41823729 [PubMed - indexed for MEDLINE]
	Missing the Forest for the Trees: Delayed Diagnosis and Management of Treatment Resistant Schizophrenia. Psychopharmacol Bull Kuriakose I, Noe G, Montgomery W, Munjal S. PMID: 41821995 [PubMed - indexed for MEDLINE]
	Non-Catatonic Mutism as a Presentation of Psychosis: A Case Study. Psychopharmacol Bull Sarangal M, Greenage MP. PMID: 41821991 [PubMed - indexed for MEDLINE]
	Incidence and Risk Factors of Clozapine-Induced Neutropenia among Patients with Schizophrenia in Taif, Saudi Arabia. Psychopharmacol Bull Altowairqi AS, Auf A, Alghamdi SS. PMID: 41821990 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 68280

Page 1 of 3414



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy